BlackRock Inc. - ENZO BIOCHEM INC ownership

ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 85 filers reported holding ENZO BIOCHEM INC in Q4 2020. The put-call ratio across all filers is 2.79 and the average weighting 0.3%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of ENZO BIOCHEM INC
ValueSharesWeighting
Q3 2023$1,337,551
-27.2%
955,394
-4.3%
0.00%
Q2 2023$1,837,201
-46.8%
998,479
-29.7%
0.00%
Q1 2023$3,451,543
+69.3%
1,420,388
-0.4%
0.00%
Q4 2022$2,038,903
-37.7%
1,425,807
-2.9%
0.00%
Q3 2022$3,275,000
+3.4%
1,468,121
-4.1%
0.00%
Q2 2022$3,167,000
-29.1%
1,530,255
-0.7%
0.00%
Q1 2022$4,468,000
-9.2%
1,540,591
+0.5%
0.00%
Q4 2021$4,920,000
-9.3%
1,533,171
+0.1%
0.00%
Q3 2021$5,423,000
+10.3%
1,532,170
-1.2%
0.00%
Q2 2021$4,915,000
-63.4%
1,550,385
-60.3%
0.00%
Q1 2021$13,445,000
+42.1%
3,908,254
+4.1%
0.00%
Q4 2020$9,463,000
+24.3%
3,755,016
+4.1%
0.00%
Q3 2020$7,615,000
-4.4%
3,608,766
+1.5%
0.00%
Q2 2020$7,964,000
-13.7%
3,555,503
-2.6%
0.00%
Q1 2020$9,233,000
-5.1%
3,649,212
-1.3%
0.00%
Q4 2019$9,728,000
-26.7%
3,698,612
+0.3%
0.00%
-100.0%
Q3 2019$13,276,000
+6.7%
3,687,265
-0.1%
0.00%0.0%
Q2 2019$12,441,000
+16.3%
3,691,434
-5.8%
0.00%
Q1 2019$10,698,000
-4.0%
3,919,114
-2.3%
0.00%
-100.0%
Q4 2018$11,149,000
-32.2%
4,010,279
+0.4%
0.00%0.0%
Q3 2018$16,451,000
-20.6%
3,992,874
-0.0%
0.00%0.0%
Q2 2018$20,729,000
+2.8%
3,993,660
+8.5%
0.00%0.0%
Q1 2018$20,165,000
-32.2%
3,679,834
+0.9%
0.00%0.0%
Q4 2017$29,721,000
-23.7%
3,646,915
-2.0%
0.00%
-50.0%
Q3 2017$38,943,000
-1.3%
3,719,521
+4.0%
0.00%0.0%
Q2 2017$39,475,000
+47.8%
3,575,732
+12.0%
0.00%
+100.0%
Q1 2017$26,713,000
+35517.3%
3,191,548
+29456.8%
0.00%
Q4 2016$75,000
+36.4%
10,7980.0%0.00%
Q3 2016$55,000
-9.8%
10,798
+4.8%
0.00%
Q2 2016$61,00010,301
+19709.6%
0.00%
Q1 2014$0520.00%
Other shareholders
ENZO BIOCHEM INC shareholders Q4 2020
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 2,392,642$6,939,00011.21%
VIEX Capital Advisors, LLC 1,435,130$4,162,0007.44%
HARBERT FUND ADVISORS, INC. 5,175,913$15,010,0006.29%
Potomac Capital Management, Inc. 496,805$1,441,0001.24%
AMH Equity Ltd 30,000$87,0000.09%
Corsair Capital Management 75,026$218,0000.05%
RBF Capital, LLC 250,359$730,0000.05%
KEMPNER CAPITAL MANAGEMENT INC. 25,475$74,0000.04%
BOOTHBAY FUND MANAGEMENT, LLC 539,954$1,566,0000.04%
Cutter & CO Brokerage, Inc. 25,777$75,0000.02%
View complete list of ENZO BIOCHEM INC shareholders